A KRAS-variant is a Biomarker of Poor Outcome, Platinum Chemotherapy Resistance and a Potential Target for Therapy in Ovarian Cancer
Molecular embryology part (2) slideshow
Molecular embryology part (2)
Sigma xi presentation final1
Venous thrombosis
340 - 05 -- processing
Riboswitches
14320057 INDAH NURYANI.pdf
Drug Metab Dispos 2
Www.soran.edu.iq Embryology Behrouz Mahmoudi Molecular Signaling 1.
MicroRNAs act sequentially and asymmetrically to control chemosensory laterality in the nematode Sarah Chang, Robert J. Johnston JR, Christian Frokjaer-Jensen,
